Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1513856/000114420419013080/tv515407_10k.htm
November 2020
November 2020
November 2020
September 2020
September 2020
July 2020
July 2020
July 2020
May 2020
May 2020
Document and Entity Information - USD ($) | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2018 | Feb. 28, 2019 | Jun. 30, 2018 | |
Document and Entity Information [Abstract] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2018 | ||
Document Fiscal Year Focus | 2018 | ||
Document Fiscal Period Focus | FY | ||
Entity Registrant Name | Neurotrope, Inc. | ||
Entity Central Index Key | 0001513856 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Public Float | $ 73,488,239 | ||
Trading Symbol | NTRP | ||
Entity Common Stock, Shares Outstanding | 12,922,370 | ||
Entity Shell Company | false | ||
Entity Emerging Growth Company | false | ||
Entity Small Business | true |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1513856/000114420419013080/tv515407_10k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Neurotrope, Inc..
Neurotrope, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Neurotrope, Inc. provided additional information to their SEC Filing as exhibits
Ticker: NTRP
CIK: 1513856
Form Type: 10-K Annual Report
Accession Number: 0001144204-19-013080
Submitted to the SEC: Fri Mar 08 2019 5:02:38 PM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Monday, December 31, 2018
Industry: Pharmaceutical Preparations